Hemodynamic and Neurohumoral Effects of Selective Endothelin A (ET _A ) Receptor Blockade in Chronic Heart Failure

Abstract

This study demonstrates for the first time in a large patient population that 3 weeks of selective ET(A) receptor blockade improves cardiac index in patients with CHF. However, long-term studies are needed to determine whether ET(A) blockade is beneficial in CHF.